Cardlytics Inc [CDLX] stock is trading at $2.07, up 1.97%. An important factor to consider is whether the stock is rising or falling in short-term value. The CDLX shares have gain 6.15% over the last week, with a monthly amount drifted -26.60%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cardlytics Inc [NASDAQ: CDLX] stock has seen the most recent analyst activity on October 11, 2024, when Evercore ISI initiated its In-line rating and assigned the stock a price target of $4. Previously, Northland Capital downgraded its rating to Market Perform on August 16, 2024, and kept the price target unchanged to $5. On August 15, 2024, downgrade downgraded it’s rating to Underperform and revised its price target to $3.50 on the stock. Needham downgraded its rating to a Hold. Lake Street downgraded its rating to a Hold and reduced its price target to $5 on August 08, 2024. Craig Hallum downgraded its rating to Hold for this stock on August 08, 2024.
Cardlytics Inc [CDLX] stock has fluctuated between $0.85 and $5.24 over the past year. Currently, Wall Street analysts expect the stock to reach $6.08 within the next 12 months. Cardlytics Inc [NASDAQ: CDLX] shares were valued at $2.07 at the most recent close of the market. An investor can expect a potential return of 193.72% based on the average CDLX price forecast.
Analyzing the CDLX fundamentals
Cardlytics Inc [NASDAQ:CDLX] reported sales of 266.20M for the trailing twelve months, which represents a drop of -9.17%. Gross Profit Margin for this corporation currently stands at 0.44% with Operating Profit Margin at -0.69%, Pretax Profit Margin comes in at -0.69%, and Net Profit Margin reading is -0.69%. To continue investigating profitability, this company’s Return on Assets is posted at -0.51, Equity is -2.79 and Total Capital is -0.79. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 3.75.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.02 points at the first support level, and at 1.98 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.10, and for the 2nd resistance point, it is at 2.14.
Ratios To Look Out For
For context, Cardlytics Inc’s Current Ratio is 1.16. On the other hand, the Quick Ratio is 1.16, and the Cash Ratio is 0.36. Considering the valuation of this stock, the price to sales ratio is 0.41, the price to book ratio is 1.87.
Transactions by insiders
Recent insider trading involved Lynton Nicholas Hollmeyer, Chief Legal & Privacy Officer, that happened on Oct 02 ’25 when 6098.0 shares were sold. Chief Executive Officer, Gupta Amit completed a deal on Oct 02 ’25 to sell 7799.0 shares. Meanwhile, Chief Financial Officer DeSieno Alexis sold 8493.0 shares on Oct 02 ’25.
